Literature DB >> 8549887

Adverse reaction to food: assessment by double-blind placebo-controlled food challenge and clinical, psychosomatic and immunologic analysis.

M H Vatn1, I A Grimstad, L Thorsen, E Kittang, I Refnin, U Malt, A Løvik, T Langeland, A Naalsund.   

Abstract

Double-blind placebo-controlled food challenge (DBPCFC) with food items applied in capsules was performed in a prospective study of 17 selected patients and 34 age- and sex-matched healthy controls in the interdisciplinary clinical setting. Protein immunoblotting showed no differences in antigenicity between foods in the capsules and the corresponding fresh foods. All patients reacted to one or more food substances during DBPCFC, with a doubtful reaction to placebo in 2 patients. Agreement between diet history and provocation was seen in 53 of 85 individual food challenges, 36 being positive with both examinations. In 22 (38%) of the 58 positive provocations, the reactions were not expected from the patients' histories. No reaction to food or placebo occurred in the control group. Related to diet history, sensitivity and specificity of provocation were 62 and 63%, respectively, with a positive predictive value of 78%. Allergy, previous gastroenterologic and infectious diseases among first-degree relatives, immunologic abnormalities and elevation of total IgE were significantly more common for the patients than controls. A positive skin prick test correlated well with diet history, but both prick test and food antibodies correlated poorly with DBPCFC. Assessment by the General Health Questionnaire showed a significant difference towards the controls. After 3-4 months of follow-up on an individually based diet, 11 of 15 patients reported general improvement of their condition. DBPCFC may be a valuable diagnostic test in addition to dietary history as a basis for elimination diet on food-intolerant patients. The effect of the elimination diet on the symptoms may also suggest a therapeutic effect or provocation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549887     DOI: 10.1159/000201270

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Subjective health complaints and modern health worries in patients with subjective food hypersensitivity.

Authors:  Ragna Lind; Gülen Arslan; Hege R Eriksen; Gudrun Kahrs; Tone Tangen Haug; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 2.  Psychological burden of food allergy.

Authors:  Martin Teufel; Tilo Biedermann; Nora Rapps; Constanze Hausteiner; Peter Henningsen; Paul Enck; Stephan Zipfel
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

3.  Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index.

Authors:  Gülen Arslan; Ragna Lind; Snorri Olafsson; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 4.  The differential diagnosis of food intolerance.

Authors:  Yurdagül Zopf; Hanns-Wolf Baenkler; Andrea Silbermann; Eckhart G Hahn; Martin Raithel
Journal:  Dtsch Arztebl Int       Date:  2009-05-22       Impact factor: 5.594

Review 5.  The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnoses.

Authors:  Martin Raithel; Michael Weidenhiller; Alexander Fritz-Karl Hagel; Urban Hetterich; Markus Friedrich Neurath; Peter Christopher Konturek
Journal:  Dtsch Arztebl Int       Date:  2013-11-15       Impact factor: 5.594

6.  Excretion of urinary histamine and N-tele methylhistamine in patients with gastrointestinal food allergy compared to non-allergic controls during an unrestricted diet and a hypoallergenic diet.

Authors:  Martin Raithel; Alexander Hagel; Heinz Albrecht; Yurdaguel Zopf; Andreas Naegel; Hanns-Wolf Baenkler; Fred Buchwald; Hans-Wolfgang Schultis; Juergen Kressel; Eckhart Georg Hahn; Peter Konturek
Journal:  BMC Gastroenterol       Date:  2015-04-01       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.